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Abstract
Background: To describe the presenting clinical features of coeliac disease in a single paediatric
centre, and to determine if the presenting features vary with age.
Methods: A review was conducted of children who had been referred with clinical suspicion of
coeliac disease to the paediatric gastroenterology department of a tertiary paediatric hospital in
Sydney, Australia. Coeliac disease was defined using standard histological criteria. Medical records
were reviewed retrospectively.
Results: Clinical data were available for 74 cases of proven coeliac disease. Only 9% of patients
were less than 2 years of age at diagnosis. Pre-school children (age <5 years) presented with
different symptoms to school children (age ≥  5 years). The most common presenting features in
younger children were diarrhoea, irritability and weight loss. However, in older children, abdominal
pain was the most common presenting feature.
Conclusion: We found a significant difference in the clinical features of coeliac disease in pre-
school compared to school age children.
Background
There has been an apparent increase in the incidence of
coeliac disease (coeliac disease) over the past 30 years [1].
For instance, the number of reported cases in the Nether-
lands increased from 0.18 per 1000 live births from
1975–1990, to 0.54 per 1000 live births 1993–1994 [1].
There is also increasing recognition that symptomatic coe-
liac disease may be the tip of the iceberg, with many more
asymptomatic cases in the community [2-4].
It is unclear whether the changing prevalence of reported
cases of coeliac disease is due to a real increase in the
number of cases, enhanced awareness of disease or more
reliable serological testing. Dietary changes, such as earlier
introduction of gluten, have been suggested as contribut-
ing to the changing presentation of coeliac disease in
some populations [5,6]. Breast feeding, in particular
breast feeding after the introduction of gluten, is protec-
tive against the development of coeliac disease [7].
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There are few data on the clinical features, incidence and
prevalence of coeliac disease in Australian populations. In
a population based screening study from a rural commu-
nity of Western Australia, 10/3001 were positive for anti-
endomysial antibodies. This community was of predomi-
nantly Anglo-Celtic origin [4]. Australians come from
diverse ethnic backgrounds, thus the prevalence reported
in this community cannot be generalised to the Australian
population.
The primary aim of this study was to describe the clinical
features of children diagnosed with coeliac disease at one
tertiary paediatric centre in Australia. Our secondary aim
was to determine the presentation patterns of coeliac dis-
ease in the local community at different ages.
Methods
A retrospective cross sectional study was conducted at Syd-
ney Children's Hospital, one of two tertiary referral paedi-
atric hospitals in Sydney, Australia. The study population
consisted of infants and children who had been referred
to the Gastroenterology Department at Sydney Children's
Hospital for investigation of possible coeliac disease
between 1997 and 2002. Subjects were identified through
records kept by the Departments of Nutrition and Dietet-
ics, Gastroenterology, and Anatomical Pathology. Ethics
approval was granted from the South East Sydney Area
Health Service Research Ethics Committee-Eastern
Section.
Cases and clinical features
Cases were defined as those with histological confirma-
tion of coeliac disease [8]. A single pathologist reviewed
all slides. Where the histological diagnosis of coeliac dis-
ease was uncertain, clinical and laboratory features,
including response to gluten free diet, were included.
The clinical details of each patient were extracted from the
medical records retrospectively. Features of interest
included presenting symptoms as well as the symptoms
and signs elicited during consultation with a paediatric
gastroenterologist. Weight and height measurements at
diagnosis were documented. SD (standard deviation)
scores were calculated using reference data [9]. The ethnic
mix for the reference population of children admitted to
Sydney Children's Hospital was described using child's
country of birth.
Laboratory investigations
The results of haemoglobin, iron studies, serum IgA, anti-
gliadin (AGA) and anti-endomysial antibodies (EMA)
were obtained from each patient's medical records. AGA
and EMA tests had been performed at SEALS (South East-
ern Area Laboratory Service, Kogarah, NSW). The SEALS
laboratories measure EMA using indirect immunoflures-
cence, anti-human FITC conjugate IgA against monkey
distal oesophagus. The slides are prepared by MeDICa
(Encinitas, CA 92024). A value of 10 is used for as positive
cut off. AGA were measured by commercial immunoassay
kits (Analytica Ltd, Castle Hill NSW Australia). The cut off
values used for children were IgA>25 and IgG >46.
Low haemoglobin values for age were defined as those
less than the reference range for age used by the hospital
laboratory (SEALS). The low end of the normal range for
children 6 months to 2 years was 104 g/L; 2–4 years 107
g/L; 4–8 years 110 g/L; 8–12 y 113 g/L; >12 y 130 g/L.
Patients were considered iron deficient on the basis of a
microcytic blood film, low serum iron, low serum ferritin,
and elevated iron binding capacity.
Statistical analysis
Data were analysed by simple descriptive analysis per-
formed manually and using Excel (Microsoft Office 97).
Fisher's Exact tests were used to compare independent
data using STATA [10]. Where data was not available,
summary statistics were performed using only the data
available.
Results
Subjects
A total of 119 patients were identified over the six year
period. Forty-three patients were excluded as there was
another medical reason to explain their histological fea-
tures or reason for dietetic referral. The medical records
were unable to be located for two patients, leaving 74 sub-
jects with coeliac disease available for analysis. The male:
female ratio of patients was 1:2. The age at diagnosis
ranged from 11 months to 14 years with median of 5.5
years. Seven patients (9% of total group) were less than 2
years of age (Figure 1). The ethnic mix (based on country
of birth) of all admissions to SCH consists of approxi-
mately 94% Australian, 2% Asian, 1% UK and Europe,
0.05% Africa, and 0.02% Pacific Islands (data compiled
by MS using admission data for Sydney Children's Hospi-
tal for 2002).
Clinical features
Sixty nine of the seventy four children had presented with
symptoms (Table 1). Full details of the presenting symp-
toms were available in 65 of the patients. Twenty nine of
these children were aged less than five (preschool) and
forty were aged five years or greater. The most common
presenting symptoms in younger children (those <5
years) were diarrhoea (59%), irritability (34%) and
weight loss (38%). In older children (≥  5 years), the most
common presenting feature was abdominal pain (55%),
followed by diarrhoea (26%). Twenty-three percent of the
symptomatic children had > 3 presenting symptoms.BMC Pediatrics 2005, 5:11 http://www.biomedcentral.com/1471-2431/5/11
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Five patients had no gastrointestinal symptoms at diagno-
sis. Four of these patients had positive coeliac serology
during routine complication screening for type 1 diabetes
(T1DM). The fifth patient had coeliac serology performed
as part of investigation into recurrent infections.
Overall, ten children were noted to have other medical
problems potentially related to the development of coe-
liac disease. Five patients had T1DM, two patients had Tri-
somy 21, two patients had juvenile rheumatoid arthritis,
and one patient had Raynaud's phenomenon. Fourteen of
Age at Presentation of Coeliac disease in the cohort of 74 subjects Figure 1
Age at Presentation of Coeliac disease in the cohort of 74 subjects. This figure illustrates the age distribution of the 
74 subjects with coeliac disease in this study. Infants less than 2 years of age represented only 12% of the population. 27% of 
subjects were aged between 4 and 5 years, 36% were aged between 5 and 10 years, 26% were more than 10 years.
Table 1: Clinical features of 69 symptomatic children with Coeliac disease
Age < 5 years n = 29 (% of group) Age ≥  5 years n = 40 (% of group)
Abdominal pain 6 (20) 25 (62.5)*
Diarrhoea 17 (59) 12 (30)*
Tiredness/lassitude 9 (31) 9 (22.5)
Abdominal distension 16 (55) 9 (22.5)*
Constipation 4 (14) 5 (12.5)
Irritability 10 (34) 6 (15)*
Mouth Ulcers 2 (7) 6 (15)
Anaemia 5 (17) 10 (25)
Weight loss or lack of expected weight gain 11 (35) 6 (15)*
Anorexia and vomiting 7 (24) 0*
(*p < 0.05) This table displays the number of subjects with each symptom. The numbers in brackets describe the percentage of the age group with 
that symptom.
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the 79 (18%) patients had a family history of coeliac dis-
ease in a first degree relative.
The mean weights and heights of the subjects with coeliac
disease were not significantly different to the reference sex
and age matched population (mean weight SD -0.45 ±
0.14; mean height SD -0.4 ± 0.17). However, 5% of the
children with coeliac disease had a weight SD score of
more than 2 SD below the mean and 12% of children had
a height SD score of more than 2 SD below the mean.
Laboratory data
Seventeen of 64 (26%) patients with haemoglobin levels
available had haemoglobin levels below the reference
range for age (mean haemoglobin 118 g/L ± 0.2). Thirty
two of 37 (86%) patients who had iron studies available
were deemed iron deficient (low serum iron and ferritin).
Of those who were biochemically iron deficient, 8 (25%)
had normal haemoglobin values for their age.
IgG AGA was elevated in 97% of cases. IgA AGA was ele-
vated in 94% of cases. There were no patients with IgA
deficiency. EMA were elevated in 97% of this group of
children. There were two patients with positive EMA anti-
bodies who had negative AGA, on the other hand there
was one patient (aged 9 years) with negative EMA who
had positive AGA.
Discussion
This study describes the clinical features at presentation in
a group of Australian children diagnosed with coeliac dis-
ease during a time of increasing awareness of this disease
and widespread availability of reliable laboratory screen-
ing tests. The children included in this retrospective
review presented with a wide variety of clinical features.
The most common clinical features of coeliac disease in
younger children were the so-called classical symptoms of
diarrhoea, irritability and weight loss. However, older
children more commonly presented with abdominal
pain. There were few cases without gastrointestinal symp-
toms in our cohort.
The clinical features of the children in this study were sim-
ilar to the clinical features described from populations in
New Zealand [11], South Yorkshire [12] and Sweden [13].
Although abdominal pain is a common symptom of older
children with coeliac disease, there is no association
between classical recurrent abdominal pain and coeliac
disease [14].
Anaemia was identified in approximately one quarter of
the cases. Furthermore, many children had laboratory evi-
dence of iron deficiency but were not anaemic at the time
of diagnosis. Unfortunately only 86% of subjects had a
full blood count taken, and 50% had blood taken for iron
studies. Thus the true prevalence of anaemia and iron
deficiency is uncertain. Cross sectional studies have iden-
tified a high prevalence of coeliac disease in patients with
iron or folate deficiency [15,16]. The incidence of coeliac
disease in patients in the community presenting only with
iron or folate deficiency has been reported at 4.7% [15].
Anaemia was reported in only 5% of children with coeliac
disease from the Netherlands [1]. In the United Kingdom,
iron deficiency anaemia was reported in approximately
20% of adults with coeliac disease. Although the current
data may have underestimated the true incidence of anae-
mia and iron deficiency, it is likely higher than that
reported in these previous cohorts.
Growth failure in height and weight was not as common
in this cohort as was described in coeliac children from
the Netherlands, where 49.7% of children had poor
growth [1]. In our study, 5% of children had a weight
more than 2 SD below the mean, and 12% of children had
a height more than 2 SD below the mean. Growth failure
is more commonly seen in children diagnosed at a
younger age than in our study [17]. The discrepancy in
reported growth failure may also be due to different defi-
nitions of growth failure. In addition, because this was a
retrospective study, it was not possible to obtain adequate
information about growth velocity or of the children's
genetic growth potential.
The children in our study were older at the time of diag-
nosis than previous surveys of children with coeliac dis-
ease. In a cohort of patients diagnosed between 1950 and
1969, 70 of 91 were less than 2 years at the time of diag-
nosis and only 3 were more than 6 years. In a smaller
cohort of children diagnosed between 1972 and 1975, 32
of 42 were less than 2 years at the time of diagnosis and 6
were greater than 6 years [18]. In the Netherlands, the pro-
portion of children with coeliac disease aged < 2 yrs has
remained at about 60% from 1975 to 1994 [1]. An epi-
demic in coeliac disease in Swedish Children in the 1980's
paralleled the change in feeding practices at the time, in
particular increased exposure to wheat, rye and barley and
decreased duration of breast feeding [5]. A prospective
study of coeliac disease in infants showed that a longer
duration of breast feeding, smaller amounts of gluten in
the diet in infants less than 12 months [17] and breast
feeding after gluten is introduced to the diet reduces the
risk of coeliac disease in infants less than 2 years [7]. Thus,
the later age of acquiring coeliac disease in the Australian
population may be due to the delayed introduction of sol-
ids in the diet of Australian children. The current recom-
mendations in Australia are to introduce solids at 6
months (NHMRC Dietary Guidelines for Children and
Adolescents in Australia 1993).BMC Pediatrics 2005, 5:11 http://www.biomedcentral.com/1471-2431/5/11
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In this study, there were relatively few cases of coeliac dis-
ease detected by the screening of at risk groups. This con-
trasts with the worldwide trend of an increased prevalence
of coeliac disease detected by screening [2,19-22]. A large
multi-centered study of children and adults in the United
States of America showed that the prevalence of celiac dis-
ease was 1:22 in first degree relatives, 1:56 in symptomatic
individuals or a disorder known to be associated with
celiac disease (type 1 diabetes, down syndrome, anemia,
arthritis, osteoporosis, infertility and short stature), and
1:133 in the not-at-risk population [23].
In our study, the best screening test in children aged over
2 years with symptoms of, or who are at risk of, coeliac
disease was IgA EMA. Other studies have shown that this
test has a sensitivity of 95–98%, specificity of 94–95%,
positive predictive value of 91–95% and negative predic-
tive value of 96–98% [24]. For children less than 2 years
of age, IgA AGA may be more reliable [24]. Increasingly
over the last few years, reports suggest that tissue-trans-
glutaminase (tTG) antibody may be even more reliable
than EMA as a screening test [25,26], and in addition is
more reproducible and reliable. This test was not available
during the period of this review. Although the utility of
these newer tests is improved compared to AGA antibod-
ies, they are not yet accepted as diagnostic tests. Any child
with symptoms suspicious of coeliac disease, even if neg-
ative serology, warrants further review by a paediatric gas-
troenterologist, as a small bowel biopsy remains the gold
standard test for diagnosis of coeliac disease.
Conclusion
Coeliac disease in children does not always present with
classical clinical features, especially in older children. The
possibility of coeliac disease should be considered in any
child presenting with diarrhoea, irritability and weight
loss, and particularly in older children with abdominal
pain. With the widespread availability of minimally inva-
sive screening tests for coeliac disease, identifying cases in
at risk groups by screening should also be considered.
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